Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
10,962,747
-
Shares change
-
-252,180
-
Total reported value, excl. options
-
$874,847,601
-
Value change
-
-$34,316,604
-
Put/Call ratio
-
65%
-
Number of buys
-
52
-
Number of sells
-
-64
-
Price
-
$79.79
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q3 2021
160 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share as of Q3 2021.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,962,747 shares
of 23,267,064 outstanding shares and own 47.12% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (1,499,213 shares), Avoro Capital Advisors LLC (1,425,000 shares), VANGUARD GROUP INC (1,071,530 shares), ARMISTICE CAPITAL, LLC (1,036,000 shares), WELLINGTON MANAGEMENT GROUP LLP (1,018,018 shares), BlackRock Inc. (915,789 shares), STATE STREET CORP (758,615 shares), Rock Springs Capital Management LP (262,500 shares), Artisan Partners Limited Partnership (220,889 shares), and GEODE CAPITAL MANAGEMENT, LLC (202,375 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.